This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:



New immunotherapy strategies in targeting complexity in the tumor microenvironment

Credit: Unsplash/CC0 Public Domain

A symposium aiming to provide a better understanding of the tumor microenvironment, immune tolerogenic niches at cancer initiation, and novel immunotherapeutic strategies in head and neck cancer patients was featured at the 52nd Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 47th Annual Meeting of the CADR. The AADOCR/CADR Annual Meeting & Exhibition took place at the Oregon Convention Center in Portland on March 15-18, 2023.

Cancer immunotherapy has arisen as a promising new treatment modality for head and neck cancer (HNC), built on an increased understanding of tumor immunology over the last two decades. However, it has become clear that not all tumors are created equal when it comes to their immune profiles, and many are resistant to immunotherapy. Thus, there is a need to better understand the complex tumor microenvironment to more accurately determine prognosis and design capable of rendering tumors susceptible to immunotherapy and the immunologic effects of conventional therapies.

Organized by Simon Young of the University of Texas Health Science Center at Houston, this symposium provided a high-level overview of exciting developments in understanding the tumor microenvironment, both in terms of the complex immunosuppressive mechanics of the extracellular matrix, the creation of an immune tolerogenic niche at cancer initiation, and how novel immunotherapeutic strategies can target the adverse the tumor immune microenvironment in head and neck cancer. A broad spectrum of expertise was represented by featured clinician-scientist speakers: topics included current challenges in HNC surgical oncologic ablation strategies and formation of the immune tolerogenic niche at cancer initiation. This was followed by novel strategies to target fibrotic inflammation and biomaterial-based strategies for cancer immunotherapy and delivery of therapeutics to the immunosuppressive .

The symposium targeted dental students, post-graduate students, dentists, dentist-scientists, and scientists who wished to expand their knowledge of the tumor immune microenvironment and how will impact head and patients. This session was geared towards clinicians and researchers alike.

More information: The symposium, "Targeting Complexity in the Tumor Microenvironment: New Immunotherapy Strategies," took place on Saturday, March 18th, 2023, at 9:45 a.m.—11:15 a.m. Pacific Daylight Time (UTC-07:00).

Provided by International Association for Dental Research
Citation: New immunotherapy strategies in targeting complexity in the tumor microenvironment (2023, March 19) retrieved 23 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment


Feedback to editors